ATP5J expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 5.612000E-01 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.879000E-01 |
Normal-vs-Stage2 |
9.913000E-01 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
2.683800E-01 |
Stage1-vs-Stage2 |
9.232400E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
2.327600E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
2.803800E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.195600E-01 |
Normal-vs-AfricanAmerican |
9.845600E-01 |
Normal-vs-Asian |
3.017800E-02 |
Caucasian-vs-AfricanAmerican |
8.533200E-01 |
Caucasian-vs-Asian |
3.410600E-01 |
AfricanAmerican-vs-Asian |
5.851600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.357200E-01 |
Normal-vs-Female |
4.235000E-01 |
Male-vs-Female |
4.089000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.861600E-01 |
Normal-vs-Extreme_Weight |
5.197600E-01 |
Normal-vs-Obese |
7.174600E-01 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
1.533840E-01 |
Normal_Weight-vs-Obese |
5.327200E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
4.769400E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.634000E-01 |
Normal-vs-Age(41-60Yrs) |
1.666820E-01 |
Normal-vs-Age(61-80Yrs) |
6.500400E-01 |
Normal-vs-Age(81-100Yrs) |
3.939200E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.152400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.279600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.301600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.341380E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.821610E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.253000E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
5.880600E-01 |
Normal-vs-Grade 3 |
5.715400E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
8.061000E-01 |
Grade 2-vs-Grade 4 |
5.880600E-01 |
Grade 3-vs-Grade 4 |
5.715400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
8.061400E-01 |
Normal-vs-N1 |
7.959800E-01 |
N0-vs-N1 |
8.946000E-01 |
|
|